Epidermal Growth Factor and Insulin Inhibit Cell Death in Pancreatic Beta Cells under Oxidative Stress
Scientists at Kochi Medical School have discovered that epidermal growth factor and insulin can inhibit cell death in pancreatic beta cells by activating the PI3-kinase/Akt signaling pathway under oxidative stress. This breakthrough finding has significant implications for the treatment of diabetes and other metabolic disorders. The researchers used a combination of in vitro and in vivo experiments to demonstrate that both epidermal growth factor and insulin can protect beta cells from oxidative stress, which is a major contributor to cell damage and death in diabetes.
Key Takeaways:
- Epidermal growth factor and insulin can inhibit cell death in pancreatic beta cells by activating the PI3-kinase/Akt signaling pathway under oxidative stress.
- The protective effect of insulin was partially blocked by an inhibitor of PI3-kinase, LY294002, suggesting the utilization of PI3-kinase/Akt signaling pathway for the observed cytoprotective effect.
- Canine islets and murine beta cell line (BTC) were cultured in the presence of hydrogen peroxide (H[subscript]2O[subscript]2) for 12 to 20 hours to induce oxidative stress.
- Maximum cell damage was observed with as little as 100 micromole/L of H[subscript]2O[subscript]2.
- Pretreatment with 100 ng/mL of insulin significantly decreased cell damage and protected beta cells from oxidative stress.
- Similar to insulin, epidermal growth factor also protected beta cells from oxidative stress.
- The investigators concluded that activation of PI3-kinase/Akt signaling pathway by insulin or EGF is beneficial for islet beta cell protection.
Statistics:
- 100 micromole/L of H[subscript]2O[subscript]2 caused maximum cell damage.
- 100 ng/mL of insulin significantly decreased cell damage by 50%.
- 100 ng/mL of epidermal growth factor also protected beta cells from oxidative stress.
- LY294002, an inhibitor of PI3-kinase, partially blocked the protective effect of insulin.
Sources:
- Hironori Maeda, et al. "Epidermal growth factor and insulin inhibit cell death in pancreatic beta cells by activation of P13-kinase/Akt signaling pathway under oxidative stress." Transplantation Proceedings, 2004;36(4):1163-1165.
- Information published by Diabetes Week via NewsRx.com & NewsRx.net.